特此公告。 中科院成都信息技术股份有限公司 2025年半年度报告披露提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 中科院成都信息技术股份有限公司2025年半年度报告全文及报告 摘要于2025年8月26日在中国证监会指定的创业板信息披露网站巨潮资 讯网（http://www.cninfo.com.cn）上披露，敬请投资者查阅。 证券代码：300678 证券简称：中科信息 公告编号：2025-065 董事会 2025 年 8 月 25 日 中科院成都信息技术股份有限公司 1 / 1 ...

| 非经营性资金占 | | | | 占用方与上 | 上市公司核算 | 2025 | 年期初占 | 2025 年半年 度占用累计 | 2025 年半年 度占用资金 | 2025 | 年半年度 | 2025 | 年半年度 | 占用形 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 用 | 资金占用方名称 | | 联关系 | 市公司的关 | 的会计科目 | 用资金余额 | | 发生金额（不 | 的利息（如 | | 偿还累计发生 金额 | | 期末占用资金 余额 | 成原因 | 占用性质 | | | | | | | | | | 含利息） | 有） | | | | | | | | 控股股东、实际 控制人及其附属 | | | | | | | | | | | | | | | | | 企业 | | | | | | | | | | | | | | | | | 小计 | | - | | - | - | | | | | | | | | | | | 前控股股东、实 | | | ...

中科院成都信息技术股份有限公司 关于举行2025年半年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 中科院成都信息技术股份有限公司（以下简称"公司"）2025年半 年度报告及其摘要于2025年8月26日公布，为更好地与广大投资者进行 交流，使投资者能够进一步了解公司经营情况，公司拟举行2025年半年 度网上业绩说明会。具体安排如下： 公司定于2025年9月3日（星期三）下午15:00-17:00采用网络远程 的方式在深圳证券交易所"互动易"平台举行2025年半年度网上业绩 说明会。投资者可登录"互动易"网站（http://irm.cninfo.com.cn）， 进入"云访谈"栏目参与本次业绩说明会。 证券代码：300678 证券简称：中科信息 公告编号：2025-068 1 / 2 证券代码：300678 证券简称：中科信息 公告编号：2025-068 次活动交流期间，投资者仍可登录活动界面进行互动提问。 欢迎广大投资者积极参与。 特此公告。 2025 年 8 月 25 日 中科院成都信息技术股份有限公司 2 / 2 公司拟出席本次网 ...

Important Notes, Table of Contents, and Definitions [Important Notes](index=2&type=section&id=%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA) The board and management affirm the semi-annual report's accuracy; no cash dividends, bonus shares, or capital reserve conversions are planned - The company's board of directors and senior management guarantee the truthfulness, accuracy, and completeness of the semi-annual report content and assume legal responsibility[4](index=4&type=chunk) - Company head Shi Zhiming, chief accountant Yin Bangming, and head of accounting department Du Li declare that the financial report in this semi-annual report is true, accurate, and complete[4](index=4&type=chunk) - The company plans not to distribute cash dividends, bonus shares, or convert capital reserves into share capital[5](index=5&type=chunk) [Table of Contents](index=3&type=section&id=%E7%9B%AE%E5%BD%95) This report's clear table of contents provides a comprehensive information index across eight main chapters, covering company overview, financials, and governance - The report comprises eight main chapters, covering comprehensive information on company operations, financials, governance, and significant matters[7](index=7&type=chunk) [Definitions](index=5&type=section&id=%E9%87%8A%E4%B9%89) This section defines common terms, including company abbreviations, key stakeholders, and critical technology concepts, ensuring accurate report understanding - The definitions section clarifies company-related entities such as 'CAS Information' and 'CAS Holdings,' along with key technology and industry terms like 'algorithm,' 'computer automated reasoning,' 'intelligent recognition and analysis technology,' 'machine vision technology,' 'IoT,' 'virtual simulation,' 'SCADA,' 'CNG,' 'big data,' 'cloud computing,' '5G,' 'blockchain,' 'ARM architecture,' 'CCOS,' 'PCOS,' 'IPD,' 'PDM,' 'PLM,' and 'AI'[10](index=10&type=chunk)[12](index=12&type=chunk)[13](index=13&type=chunk) Company Profile and Key Financial Indicators [Company Profile](index=8&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E7%AE%80%E4%BB%8B) CAS Information Technology Co., Ltd. (stock code: 300678) is listed on the Shenzhen Stock Exchange, with Shi Zhiming as legal representative - The company's stock abbreviation is 'CAS Information,' stock code '300678,' listed on the Shenzhen Stock Exchange[15](index=15&type=chunk) - The company's legal representative is Shi Zhiming[15](index=15&type=chunk) [Contact Persons and Information](index=8&type=section&id=%E4%BA%8C%E3%80%81%E8%81%94%E7%B3%BB%E4%BA%BA%E5%92%8C%E8%81%94%E7%B3%BB%E6%96%B9%E5%BC%8F) Liu Xiaobing (Board Secretary) and Wu Linlin (Securities Affairs Representative) are located at 1369 Kezhi Road, Xinglong Street, Tianfu New Area, Sichuan, with contact details provided - Liu Xiaobing is the Board Secretary, Wu Linlin is the Securities Affairs Representative, and the contact address is 1369 Kezhi Road, Xinglong Street, Tianfu New Area, Sichuan Province[16](index=16&type=chunk) [Other Information](index=8&type=section&id=%E4%B8%89%E3%80%81%E5%85%B6%E4%BB%96%E6%83%85%E5%86%B5) No changes occurred in the company's registered address, office, website, email, information disclosure, or registration details during the reporting period; specifics are in the 2024 annual report - The company's contact information, information disclosure and filing locations, and registration status remained unchanged during the reporting period, with specific details available in the 2024 annual report[17](index=17&type=chunk)[18](index=18&type=chunk)[19](index=19&type=chunk) [Key Accounting Data and Financial Indicators](index=9&type=section&id=%E5%9B%9B%E3%80%81%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) Revenue decreased by **6.61%**, net profit attributable to shareholders by **24.48%**, and EPS by **24.40%**; operating cash flow improved, while total assets and net assets slightly declined Key Accounting Data and Financial Indicators (H1 2025 vs. Prior Year Period) | Indicator | Current Period (CNY) | Prior Year Period (CNY) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 141,554,857.56 | 151,568,739.37 | -6.61% | | Net Profit Attributable to Shareholders | 3,767,522.41 | 4,988,463.86 | -24.48% | | Net Profit Attributable to Shareholders Excluding Non-Recurring Items | 1,943,823.05 | 1,939,401.37 | 0.23% | | Net Cash Flow from Operating Activities | -84,851,329.01 | -99,794,118.62 | 14.97% | | Basic Earnings Per Share (CNY/share) | 0.0127 | 0.0168 | -24.40% | | Diluted Earnings Per Share (CNY/share) | 0.0127 | 0.0168 | -24.40% | | Weighted Average Return on Net Assets | 0.44% | 0.58% | -0.14% | | **Period-End Indicators** | **Current Period-End (CNY)** | **Prior Year-End (CNY)** | **Change from Prior Year-End (%)** | | Total Assets | 1,144,729,969.17 | 1,192,790,641.91 | -4.03% | | Net Assets Attributable to Shareholders | 845,472,864.70 | 856,524,656.94 | -1.29% | [Differences in Accounting Data Under Domestic and International Accounting Standards](index=9&type=section&id=%E4%BA%94%E3%80%81%E5%A2%83%E5%86%85%E5%A4%96%E4%BC%9A%E8%AE%A1%E5%87%86%E5%88%99%E4%B8%8B%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%B7%AE%E5%BC%82) No differences existed in net profit or net assets between financial reports disclosed under international/foreign accounting standards and Chinese accounting standards - During the reporting period, the company had no differences in net profit and net assets between financial reports disclosed under International Accounting Standards and Chinese Accounting Standards[21](index=21&type=chunk) - During the reporting period, the company had no differences in net profit and net assets between financial reports disclosed under foreign accounting standards and Chinese Accounting Standards[22](index=22&type=chunk) [Non-Recurring Gains and Losses Items and Amounts](index=9&type=section&id=%E5%85%AD%E3%80%81%E9%9D%9E%E7%BB%8F%E5%B8%B8%E6%80%A7%E6%8D%9F%E7%9B%8A%E9%A1%B9%E7%9B%AE%E5%8F%8A%E9%87%91%E9%A2%9D) Total non-recurring gains and losses amounted to **CNY 1,823,699.36**, primarily from government subsidies, entrusted investments, and other non-operating income and expenses Non-Recurring Gains and Losses Items and Amounts | Item | Amount (CNY) | | :--- | :--- | | Government subsidies recognized in current profit or loss (excluding those closely related to normal business operations, compliant with national policies, enjoyed by fixed standards, and with a continuous impact on company profit or loss) | 1,173,743.46 | | Gains or losses from entrusted investments or asset management | 626,366.58 | | Other non-operating income and expenses apart from the above | 235,246.84 | | Less: Income tax impact | 211,657.52 | | Total | 1,823,699.36 | Management Discussion and Analysis [Main Businesses Engaged by the Company During the Reporting Period](index=11&type=section&id=%E4%B8%80%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%85%AC%E5%8F%B8%E4%BB%8E%E4%BA%8B%E7%9A%84%E4%B8%BB%E8%A6%81%E4%B8%9A%E5%8A%A1) The company's core business, centered on intelligent recognition and analysis technology, provides IT solutions for smart government, manufacturing, cities, and health, maintaining domestic leadership and expanding into smart healthcare - The company's main business, centered on intelligent recognition and analysis technology, provides IT solutions and related services to industry clients in digital conferencing, tobacco, banknote inspection, oil and gas, government, and other sectors[87](index

脑机接口概念资金流入榜 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 002195 | 岩山科 技 | 3.55 | 12.85 | 37957.04 | 8.75 | | 600775 | 南京熊 猫 | 10.01 | 19.70 | 21253.20 | 12.81 | | 002173 | 创新医 疗 | 10.02 | 25.73 | 12956.12 | 4.97 | | 002465 | 海格通 信 | 0.15 | 6.22 | 12215.09 | 5.72 | | 301293 | 三博脑 科 | 8.51 | 24.66 | 8259.88 | 3.15 | | 300678 | 中科信 息 | 1.24 | 8.74 | 8140.51 | 8.39 | 截至8月14日收盘，脑机接口概念上涨0.92%，位居概念板块涨幅第3，板块内，18股上涨，博拓生物 20%涨停，创新医疗、南京熊猫等涨停，三博 ...

Group 1 - The core viewpoint of the article is that Minsheng Securities has given a recommendation rating to Zhongke Information (300678.SZ) based on its leading position in the domestic artificial intelligence industry and its comprehensive information solutions [2] - The company is recognized as a leading provider of overall solutions for industry informationization in the artificial intelligence sector [2] - Zhongke Information has diversified its operations across multiple fields, ensuring technological leadership and potential continuous benefits from AI empowerment [2] - The scale of China's artificial intelligence industry is continuously growing, supported by strong government policies [2]

Investment Rating - The report gives a "Buy" rating for the company, with a target price of 36.89 CNY [6]. Core Viewpoints - The company is a leading provider of AI-based industry information solutions in China, focusing on high-speed machine vision and big data technologies across various sectors such as smart governance, intelligent manufacturing, smart cities, and smart healthcare [1][2]. - The company has shown consistent revenue growth from 2018 to 2023, reaching 591 million CNY in 2023, with a compound annual growth rate (CAGR) of 11.43%. However, a decline in revenue is expected in 2024 due to project delays and reduced industry demand [2][28]. - The company is positioned to benefit from the growing AI industry in China, supported by strong government policies and initiatives aimed at promoting AI and robotics [3][55]. Summary by Sections 1. Company Overview - The company is recognized as a high-tech enterprise and has received numerous awards for its technological achievements, with a strong backing from the Chinese Academy of Sciences [1][14]. - It has a clear shareholding structure, with major shareholders including the Chinese Academy of Sciences, which enhances its credibility and market position [16][19]. 2. Market Position and Growth Potential - The company has diversified its operations across multiple sectors, ensuring technological leadership and continuous benefits from AI applications [2][3]. - The AI industry in China is experiencing rapid growth, with significant government support, which is expected to benefit the company in the long term [3][55]. 3. Financial Forecast and Investment Recommendations - The company is projected to generate revenues of 585 million CNY, 681 million CNY, and 799 million CNY in 2025, 2026, and 2027, respectively, with corresponding net profits of 29 million CNY, 39 million CNY, and 46 million CNY [4][5]. - The report suggests a price-to-sales (PS) valuation approach, with PS ratios expected to decrease from 22X in 2024 to 14X by 2027, indicating a favorable investment opportunity [4][5].

Group 1 - The brain-computer interface sector opened high, with Innovation Medical (002173) hitting the limit-up price at the opening [1] - Sanbo Brain Science (301293), Jihua Group (601718), Zhongke Information (300678), and Xiangyu Medical also experienced upward movement [1]

Core Viewpoint - Zhongke Information (300678) is focused on providing information technology solutions based on intelligent recognition and analysis technology, with applications in various sectors including government, tobacco, and oil and gas industries [2][5]. Group 1: Business Overview - The company primarily offers information technology solutions, including both software and hardware, with a focus on high-speed machine vision and intelligent analysis technology [2][5]. - Key application areas include smart governance, intelligent manufacturing, and smart health, with a strong emphasis on digital transformation across various industries [2][3]. - The company has a leading market position in providing digital solutions for major government meetings and is the only global supplier capable of offering detection technology for the entire lifecycle of banknote printing [2][3]. Group 2: Recent Developments - The artificial intelligence anesthesia robot, developed in collaboration with Sichuan University West China Hospital, has entered clinical trials after four years of research, demonstrating its capability in surgical anesthesia assistance [4]. - The intelligent loading robot and intelligent paving robot are currently in testing phases, with plans for industrial promotion in the future [4]. Group 3: Financial Performance - In Q1 2025, the company reported a main revenue of 53.1853 million yuan, a year-on-year decrease of 39.0%, and a net profit attributable to shareholders of 3.19 million yuan, down 57.96% [5]. - The company's debt ratio stands at 24.2%, with an investment income of 50.408 million yuan and a gross profit margin of 38.38% [5].

Group 1 - The company, Zhongke Information, is currently conducting field trials for its first phase of intelligent loading robots, while the second phase is focused on functional optimization and enhancement [1] - The intelligent paving robot is in the testing phase [1] - The company aims to promote industrialization in the future [1]